Company profile
Biosergen company profile
Biosergen develops variants of nystatin with improved properties. Its pipeline products include S44HP, an antibiotic that is more potent than nystatin against several fungal pathogens; and nystatin analogues produced through manipulation of the nystatin biosynthetic genes.
Business identity
- Website
- https://www.biosergen.net
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2004-01-01, Year
Headquarters
- Headquarters
- Trondheim, Trøndelag, Norway
- Postal code
- 7034
- Country code
- NO
- Continent
- Europe